Gregory Mullen

4.9k total citations · 1 hit paper
77 papers, 3.6k citations indexed

About

Gregory Mullen is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Gregory Mullen has authored 77 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Immunology, 27 papers in Radiology, Nuclear Medicine and Imaging and 18 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Gregory Mullen's work include Radiopharmaceutical Chemistry and Applications (23 papers), Malaria Research and Control (18 papers) and Complement system in diseases (12 papers). Gregory Mullen is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (23 papers), Malaria Research and Control (18 papers) and Complement system in diseases (12 papers). Gregory Mullen collaborates with scholars based in United Kingdom, United States and France. Gregory Mullen's co-authors include Philip J. Blower, Alessandra Mazzoni, Cynthia A. Leifer, David M. Segal, David R. Davies, Jessica K. Bell, Carole A. Long, Jason L. J. Dearling, Jason S. Lewis and Louis H. Miller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Gregory Mullen

75 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Leucine-rich repeats and pathogen recognition in Toll-like receptors

2003 612 citations Jessica K. Bell, Gregory Mullen et al. Trends in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gregory Mullen United Kingdom	33	1.3k	835	718	686	580	77	3.6k
Itaru Kato Japan	33	751 0.6×	302 0.4×	211 0.3×	1.5k 2.2×	591 1.0×	141	3.8k
Bo Åkerström Sweden	36	683 0.5×	800 1.0×	603 0.8×	2.1k 3.0×	168 0.3×	119	4.5k
Nicole M. Thielens France	47	4.2k 3.1×	675 0.8×	402 0.6×	1.5k 2.2×	253 0.4×	182	6.2k
Thomas Vorup‐Jensen Denmark	32	2.6k 1.9×	439 0.5×	282 0.4×	1.1k 1.6×	137 0.2×	102	4.4k
G.R. Andersen Denmark	48	1.9k 1.4×	463 0.6×	253 0.4×	3.6k 5.2×	355 0.6×	140	6.1k
Hugues Lortat‐Jacob France	53	2.1k 1.6×	490 0.6×	324 0.5×	3.8k 5.5×	1.3k 2.2×	146	8.1k
Grzegorz Dubin Poland	33	972 0.7×	383 0.5×	155 0.2×	1.9k 2.8×	1.8k 3.1×	120	4.3k
Michael W. Fanger United States	42	2.9k 2.2×	1.5k 1.8×	354 0.5×	1.7k 2.5×	693 1.2×	124	5.7k
Hattie D. Gresham United States	34	3.3k 2.4×	405 0.5×	227 0.3×	2.7k 4.0×	384 0.7×	47	6.9k
Kathryn E. Luker United States	36	1.4k 1.0×	267 0.3×	241 0.3×	1.8k 2.6×	2.0k 3.5×	76	4.9k

Countries citing papers authored by Gregory Mullen

Since Specialization

Citations

This map shows the geographic impact of Gregory Mullen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Mullen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Mullen more than expected).

Fields of papers citing papers by Gregory Mullen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Mullen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Mullen. The network helps show where Gregory Mullen may publish in the future.

Co-authorship network of co-authors of Gregory Mullen

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Mullen. A scholar is included among the top collaborators of Gregory Mullen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Mullen. Gregory Mullen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mullen, Gregory, Arun Rai, David M. Hoenig, et al.. (2024). Ureteral Stricture Disease after Mitomycin Gel Treatment. Videourology. 38(1). 1–2.

Hofman, Michael S., Peter Eu, Price Jackson, et al.. (2017). Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of ⁶⁸Ga-Tris(Hydroxypyridinone)-PSMA PET/CT in Patients with Prostate Cancer. Journal of Nuclear Medicine. 59(4). 625–631. 51 indexed citations

Meszaros, Levente K., Ehsan Sharif‐Paghaleh, James R. Ballinger, et al.. (2014). [89Zr]Oxinate4 for long-term in vivo cell tracking by positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging. 42(2). 278–287. 86 indexed citations

Badar, Adam, Jennifer Williams, Rafael T. M. de Rosales, et al.. (2014). Optimising the radiolabelling properties of technetium tricarbonyl and His-tagged proteins. EJNMMI Research. 4(1). 14–14. 32 indexed citations

Livieratos, Lefteris, B. Sawyer, TH Lee, et al.. (2014). Imaging Inflammation in Asthma: Real Time, Differential Tracking of Human Neutrophil and Eosinophil Migration in Allergen Challenged, Atopic Asthmatics in Vivo. EBioMedicine. 1(2-3). 173–180. 12 indexed citations

Livieratos, Lefteris, B. Sawyer, TH Lee, et al.. (2013). Real-time differential tracking of human neutrophil and eosinophil migration in vivo. Journal of Allergy and Clinical Immunology. 133(1). 233–239.e1. 27 indexed citations

Hueting, Rebekka, Richard Tavaré, Jonathan R. Dilworth, & Gregory Mullen. (2013). Copper-64 radiolabelling of the C2A domain of synaptotagmin I using a functionalised bis(thiosemicarbazone): A pre- and post-labelling comparison. Journal of Inorganic Biochemistry. 128. 108–111. 9 indexed citations

Szanda, Istvan, Jane E. Mackewn, Gergely Patay, et al.. (2011). National Electrical Manufacturers Association NU-4 Performance Evaluation of the PET Component of the NanoPET/CT Preclinical PET/CT Scanner. Journal of Nuclear Medicine. 52(11). 1741–1747. 100 indexed citations

Badar, Adam, James M. McDonnell, Reza Razavi, et al.. (2011). Recombinant Complement Receptor 2 Radiolabeled with [99mTc(CO)3]+ : A Potential New Radiopharmaceutical for Imaging Activated Complement. PLoS ONE. 6(4). e18275–e18275. 13 indexed citations

10.

Tavaré, Richard, Pervinder Sagoo, Yakup Tanriver, et al.. (2011). Monitoring of In Vivo Function of Superparamagnetic Iron Oxide Labelled Murine Dendritic Cells during Anti-Tumour Vaccination. PLoS ONE. 6(5). e19662–e19662. 33 indexed citations

11.

Ellis, Ruth D., Donna Shaffer, Carole A. Long, et al.. (2010). Phase 1 Trial of the Plasmodium falciparum Blood Stage Vaccine MSP142-C1/Alhydrogel with and without CPG 7909 in Malaria Naïve Adults. PLoS ONE. 5(1). e8787–e8787. 67 indexed citations

12.

Crompton, Peter D., Greta E. Weiss, Chiung‐Yu Huang, et al.. (2009). The TLR9 Ligand CpG Promotes the Acquisition of Plasmodium falciparum -Specific Memory B Cells in Malaria-Naive Individuals. The Journal of Immunology. 182(5). 3318–3326. 61 indexed citations

13.

Mullen, Gregory, Ruth D. Ellis, Kazutoyo Miura, et al.. (2008). Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria. PLoS ONE. 3(8). e2940–e2940. 85 indexed citations

14.

Miura, Kazutoyo, Hong Zhou, Gregory Mullen, et al.. (2007). Purified IGGS from unvaccinated malians interfere with the biological activity of apical membrane antigen 1-specific IGGS as judged by the in vitro growth inhibition assay. American Journal of Tropical Medicine and Hygiene. 77(5). 4–4. 3 indexed citations

15.

Mullen, Gregory, Joan Aebig, G Dobrescu, et al.. (2007). Enhanced antibody production in mice to the malaria antigen AMA1 by CPG 7909 requires physical association of CpG and antigen. Vaccine. 25(29). 5343–5347. 23 indexed citations

16.

Aebig, Joan, Gregory Mullen, G Dobrescu, et al.. (2007). Formulation of vaccines containing CpG oligonucleotides and alum. Journal of Immunological Methods. 323(2). 139–146. 45 indexed citations

17.

Kennedy, Margaret, Gregory Mullen, Cynthia A. Leifer, et al.. (2004). A Complex of Soluble MD-2 and Lipopolysaccharide Serves as an Activating Ligand for Toll-like Receptor 4. Journal of Biological Chemistry. 279(33). 34698–34704. 96 indexed citations

18.

Mazzoni, Alessandra, Cynthia A. Leifer, Gregory Mullen, et al.. (2003). Cutting Edge: Histamine Inhibits IFN-α Release from Plasmacytoid Dendritic Cells. The Journal of Immunology. 170(5). 2269–2273. 66 indexed citations

19.

Bell, Jessica K., Gregory Mullen, Cynthia A. Leifer, et al.. (2003). Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends in Immunology. 24(10). 528–533. 612 indexed citations breakdown →

20.

Liversidge, Janet, et al.. (1993). Retinal Pigment Epithelial Cells Modulate Lymphocyte Function at the Blood-Retina Barrier by Autocrine PGE2 and Membrane-Bound Mechanisms. Cellular Immunology. 149(2). 315–330. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact